Chinese biotechs can run trials 50–70% faster – our report shows where that speed is paying off, and where the road narrows.
Link as first comment.

Chinese biotechs can run trials 50–70% faster – our report shows where that speed is paying off, and where the road narrows.
Link as first comment.